Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million
Innocan Pharma meldet Abschluss der Privatplatzierung mit einem Bruttoerlös von rund 2 Millionen C$
Latest Press release:
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million
NEUESTE PRESSEMITTEILUNG:
Innocan Pharma meldet Abschluss der Privatplatzierung mit einem Bruttoerlös von rund 2 Millionen C$
Q2 2023 Financial Statement
Canadian Securities Exchange (CSE)
SYMBOL: INNO
Frankfurt Stock Exchange (FSE)
SYMBOL: FRA – IP4
US Stock Exchange (OTC)
SYMBOL: INNPF
Email us - [email protected]